Questions raised over hydroxychloroquine study which caused WHO to halt trials for Covid-19

Posted by on May 27, 2020 10:27 pm
Categories: Global Stories

Exclusive: Australian researchers query origin of data used for Lancet study, but stress there is no evidence drug is a safe or effective treatment

Sign up for Guardian Australia’s daily coronavirus email
Download the free Guardian app to get the most important news notifications

Questions have been raised by Australian infectious disease researchers about a study published in the Lancet which prompted the World Health Organization to halt global trials of the drug hydroxychloroquine to treat Covid-19.

The study published on Friday found Covid-19 patients who received the malaria drug were dying at higher rates and experiencing more heart-related complications than other virus patients. The large observational study analysed data from nearly 15,000 patients with Covid-19 who received the drug alone or in combination with antibiotics, comparing this data with 81,000 controls who did not receive the drug.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *